Vgl-4, also known as Vestigial-like protein 4, is a protein encoded by the VGLL4 gene in humans. It is part of the Vestigial-like protein family, which is known to be involved in transcriptional coactivation. Members of this family, including Vgl-4, are known to interact with transcription factors to modulate gene expression, playing essential roles in various cellular processes such as development, differentiation, and growth.
Vgl-4 has been particularly associated with the regulation of the Hippo signaling pathway, a crucial pathway involved in organ size control, cell proliferation, and apoptosis. Through its interaction with YAP, a major effector in the Hippo pathway, Vgl-4 can influence the transcriptional activity of various genes involved in these cellular processes. Additionally, Vgl-4 has been implicated in the suppression of cancer cell growth and invasion in various types of cancers, suggesting a potential tumor-suppressive role.
SEE ALSO...
Items 11 to 12 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Diethylstilbestrol | 56-53-1 | sc-204720 sc-204720A sc-204720B sc-204720C sc-204720D | 1 g 5 g 25 g 50 g 100 g | $71.00 $287.00 $547.00 $1098.00 $2185.00 | 3 | |
DES may modulate Vgl-4 expression by binding to estrogen receptors and affecting transcriptional activity. | ||||||
β-Estradiol | 50-28-2 | sc-204431 sc-204431A | 500 mg 5 g | $63.00 $182.00 | 8 | |
Estradiol may influence Vgl-4 expression through estrogen receptors, affecting gene transcription processes. | ||||||